Shares of Ocugen Inc. OCGN shed 5.16% to $0.83 Wednesday, on what proved to be an all-around positive trading session for the ...

Ocugen Inc. closed $1.23 below its 52-week high ($2.11), which the company reached on March 25th.

Maxim Group has recently initiated Ocugen Inc (OCGN) stock to Buy rating, as announced on October 15, 2024, according to Finviz. Earlier, on March 1, 2023, Chardan Capital Markets had raised the stock ...

Geode Capital Management LLC grew its stake in shares of Ocugen, Inc. (NASDAQ:OCGN – Free Report) by 6.3% in the third quarter, according to its most recent disclosure with the SEC. The fund owned ...

Ocugen Inc (OCGN) stock saw a modest uptick, ending the day at $0.9 which represents a slight increase of $0.09 or 11.11% from the prior close of $0.81. The stock opened at $0.87 and touched a low of ...

It was a strong year for the ASX, which climbed to 24 new record highs on hopes of interest rate cuts. However, there is likely to be significant volatility in 2025 as investors try to work out ...

The best brokerage accounts have minimal fees, lots of investment options and access to advanced stock trading tools. Many provide educational resources that help you determine what stocks to buy.

10.27% of the stock is owned by hedge funds and other institutional investors. OCGN has been the subject of a number of analyst reports. Maxim Group initiated coverage on shares of Ocugen in a ...

See how we rate products and services to help you make smart decisions with your money. Stock trading apps empower investors to buy and sell securities directly from the convenience of their ...

Ocugen, Inc. announced that the Data and Safety Monitoring Board has approved the continuation of the second phase of the Phase 1/2 OCU410 ArMaDa clinical trial for treating geographic atrophy (GA ...